- Molecules
- 9
MedsAcross lists 9 molecules linked to Head and neck squamous cell carcinoma, each with brands, manufacturers and supply from India for licensed hospitals and physicians.
Medicines used
Molecules linked to this condition in public data. The prescriber decides which treatment is right.
- FluorouracilOrphanNucleoside Metabolic Inhibitor13 presentations3 brandsL01BC02
- PaclitaxelOrphanMicrotubule Inhibitor10 presentations8 brandsL01CD01
- CarboplatinPlatinum-based Drug6 presentations1 brandL01XA02
- GemcitabineNucleoside Metabolic Inhibitor13 presentations2 brandsL01BC05
- CisplatinPlatinum-based Drug5 presentations1 brandL01XA01
- PalbociclibKinase Inhibitor6 presentations3 brandsL01EF01
- NivolumabOrphanProgrammed Death Receptor-1 Blocking Antibody4 presentations2 brandsL01FF01
- CetuximabOrphanEpidermal Growth Factor Receptor Antagonist2 presentations2 brandsL01FE01
- PembrolizumabOrphanProgrammed Death Receptor-1 Blocking Antibody1 presentation1 brandL01FF02
Access for rare diseases
Medicines for rare diseases are often not registered in the patient's country. Named-patient and special access routes let a physician or hospital import them legally.
Orphan and rare disease medicinesFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Need a medicine for Head and neck squamous cell carcinoma?
Physicians and hospitals can request named-patient supply. We guide you through the documents your country requires.